QT
DCPH

Quantamental Technologies’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Quantamental Technologies’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,059
Closed -$24K – 1884
2019
Q2 		$24K Buy
+1,059
New +$24.8K 0.01% 1106

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Quantamental Technologies's DCPH Position: Q3 2019 in Review

Quantamental Technologies sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2019, closing a stake of 1,059 shares — an estimated $24K sold.

Quantamental Technologies first reported a position in DCPH in Q2 2019 and held it in 1 quarter. The position peaked at $24K in Q2 2019. 122 funds tracked by Wall St. Rank hold DCPH as of Q3 2019.

  • Quantamental Technologies reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Quantamental Technologies sold 1,059 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $24K.
  • Quantamental Technologies first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Quantamental Technologies's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $24K in Q2 2019.
  • 122 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Quantamental Technologies's 13F filing for Q3 2019, filed 8 Nov 2019.